UUÂãÁÄÖ±²¥

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

12th Annual Biomarkers Congress

21 - 22 February 2017, Manchester, United Kingdom


Introduction
Pur renowned congress will bring together over 300 attendees, speakers and vendor companies from pharmaceutical and biotechnology companies as well as academia.  
 
In line with the current industry trends, the flagship event this year focuses on the discovery, development and clinical development of biomarkers in Autoimmune, Immuno-oncology, Neuroscience, Oncology as well as Cardiovascular, Rheumatology, COPD, Rare Diseases and Microbiome. Our expert speakers will also cover innovations in Biomarker research such as imaging biomarkers and assay development, big data challenges in biomarker research, new advances in biomarker technologies and platforms; insights into the human proteome atlas, population genetics, systems biology and their implications in Biomarker development. Do not miss out on gaining insights on the role of biomarkers in clinical development, clinical trials and clinical diagnostics.  
 
Sponsored by over 50 international leading solution provider companies, the two-day congress highlights formal or informal discussions and pre-organised 1-2-1 meetings 
 
For the latest updates to the programme, our complimentary webinars, and attendance opportunities, please visit our website at www.biomarkers-congress.com. 
Speakers
  • Mark E. Curran, Vice President Systems Pharmacology and Biomarkers, Janssen R&D United Kingdom
  • Johan Luthman, Vice President, Neuroscience Clinical Development, Eisai United Kingdom
  • Meena Subramanyam, Vice President, Translational, Sciences & Technology, Biogen United Kingdom
  • Amir Handzel, Director, Diagnostics, Translational and Personalized Medicine, AstraZeneca United Kingdom
  • Jonathan Moggs, Director, Novartis Institutes for Biomedical Research, Switzerland United Kingdom
  • Andreas Schuppert, Director, Bayer Technology Services GmbH BTS-TD, Bayer United Kingdom

Venue
Manchester Central Convention Complex

Manchester Central Convention Complex, Petersfield, Petersfield, Manchester, M2 3GX, United Kingdom

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*